Bank of Nova Scotia’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$433K Buy
22,493
+1,104
+5% +$21.7K ﹤0.01% 931
2025
Q4
$405K Buy
+21,389
New +$396K ﹤0.01% 979
2024
Q4
Sell
-22,775
Closed -$424K 1113
2024
Q3
$424K Sell
22,775
-1,932
-8% -$32.6K ﹤0.01% 850
2024
Q2
$380K Buy
24,707
+194
+0.8% +$2.77K ﹤0.01% 872
2024
Q1
$362K Buy
+24,513
New +$339K ﹤0.01% 886
2023
Q3
Sell
-43,662
Closed -$514K 1054
2023
Q2
$514K Buy
43,662
+6,615
+18% +$75.3K ﹤0.01% 805
2023
Q1
$426K Buy
37,047
+11,186
+43% +$138K ﹤0.01% 885
2022
Q4
$321K Sell
25,861
-25,871
-50% -$330K ﹤0.01% 996
2022
Q3
$679K Buy
+51,732
New +$764K ﹤0.01% 907
2020
Q2
Sell
-25,259
Closed -$276K 1035
2020
Q1
$276K Buy
+25,259
New +$466K ﹤0.01% 833

Other funds holding SBRA

Bank of Nova Scotia's SBRA Position: Q1 2026 in Review

Bank of Nova Scotia increased its Sabra Healthcare REIT (SBRA) stake by 5.2% in Q1 2026, buying an estimated $21.7K and bringing the position to 22,493 shares worth $433K. The position accounts for ﹤0.01% of the portfolio, ranked #931.

Bank of Nova Scotia first reported a position in SBRA in Q1 2020 and has held it in 10 quarters since. The position peaked at $679K in Q3 2022. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • Bank of Nova Scotia held 22,493 shares of Sabra Healthcare REIT worth $433K as of Q1 2026.
  • Bank of Nova Scotia bought 1,104 Sabra Healthcare REIT shares in Q1 2026, an estimated $21.7K.
  • Sabra Healthcare REIT made up ﹤0.01% of Bank of Nova Scotia's portfolio in Q1 2026, its #931 holding.
  • Bank of Nova Scotia first reported a position in Sabra Healthcare REIT in Q1 2020 and has held it in 10 quarters since.
  • Bank of Nova Scotia's Sabra Healthcare REIT position peaked at $679K in Q3 2022.
  • 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.